Related Experiment Video

Updated: Aug 18, 2026

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

[Current understanding of primary biliary cirrhosis]

L Iu Il'ichenko, E V Golovanova, T M Tsaregorodtseva

    Terapevticheskii Arkhiv
    |April 6, 2005
    PubMed
    Abstract

    Insights

    Primary biliary cirrhosis (PBC) variants were identified, with antimitochondrial antibodies type M2 (AMAM2) showing diagnostic and prognostic value. AMAM2-positive PBC patients exhibited more severe disease characteristics.

    Area of Science:

    • Hepatology
    • Immunology
    • Internal Medicine

    Context:

    • Primary biliary cirrhosis (PBC) is a chronic liver disease with variable clinical presentations.
    • Understanding the distinct disease courses is crucial for effective patient management.

    Purpose:

    • To characterize the different clinical courses of primary biliary cirrhosis (PBC).
    • To investigate the role of antimitochondrial antibodies type M2 (AMAM2) in PBC.
    • To establish the diagnostic and prognostic significance of AMAM2 in PBC.

    Summary:

    • This study analyzed 150 PBC patients using comprehensive clinical, biochemical, immunological, and morphological assessments.
    • Antimitochondrial antibodies type M2 (AMAM2) were detected in 85.4% of PBC patients, correlating positively with disease activity.
    • AMAM2-positive patients presented more frequently with extrahepatic manifestations, overlap syndrome, and higher disease activity compared to AMAM2-negative patients.

    Impact:

    • Identified distinct PBC variants: classic AMAM2-positive, AMAM2-negative, and PBC overlapping with autoimmune hepatitis.
    • Demonstrated that AMAM2 concentration serves as a valuable diagnostic and prognostic marker in primary biliary cirrhosis.
    • Highlights the importance of AMAM2 status for predicting disease severity and extrahepatic involvement in PBC patients.

    Related Concept Videos

    Cirrhosis I: Introduction01:23

    Cirrhosis I: Introduction

    Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
    Chronic Pancreatitis I: Introduction01:25

    Chronic Pancreatitis I: Introduction

    Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
    Chronic Pancreatitis I: Introduction01:24

    Chronic Pancreatitis I: Introduction

    The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
    Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
    Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
    Cirrhosis II: Pathophysiology01:24

    Cirrhosis II: Pathophysiology

    Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
    Chronic Pancreatitis II: Pathophysiology01:21

    Chronic Pancreatitis II: Pathophysiology

    Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
    Diseases of the Liver and Gallbladder01:26

    Diseases of the Liver and Gallbladder

    Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
    Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...